key: cord-0700288-pfa79p3i
authors: Keeling, Matt J.; Dyson, Louise; Guyver-Fletcher, Glen; Holmes, Alex; Semple, Malcolm G; Tildesley, Michael J.; Hill, Edward M.
title: Fitting to the UK COVID-19 outbreak, short-term forecasts and estimating the reproductive number.
date: 2020-08-12
journal: medRxiv
DOI: 10.1101/2020.08.04.20163782
sha: 041647f81f38c5e5ac2d136d8a68f4cfcdc19450
doc_id: 700288
cord_uid: pfa79p3i

The COVID-19 pandemic has brought to the fore the need for policy makers to receive timely and ongoing scientific guidance in response to this recently emerged human infectious disease. Fitting mathematical models of infectious disease transmission to the available epidemiological data provides a key statistical tool for understanding the many quantities of interest that are not explicit in the underlying epidemiological data streams. Of these, the basic reproductive ratio, R, has taken on special significance in terms of the general understanding of whether the epidemic is under control (R < 1). Unfortunately, none of the epidemiological data streams are designed for modelling, hence assimilating information from multiple (often changing) sources of data is a major challenge that is particularly stark in novel disease outbreaks. Here, we present in some detail the inference scheme employed for calibrating the Warwick COVID-19 model to the available public health data streams, which span hospitalisations, critical care occupancy, mortality and serological testing. We then perform computational simulations, making use of the acquired parameter posterior distributions, to assess how the accuracy of short-term predictions varied over the timecourse of the outbreak. To conclude, we compare how refinements to data streams and model structure impact estimates of epidemiological measures, including the estimated growth rate and daily incidence.

In late 2019, accounts emerged from Wuhan city in China of a virus of unknown origin that was leading 2 to a cluster of pneumonia cases [1] . The virus was identified as a novel strain of coronavirus on 7th 3 January 2020 [2] , subsequently named Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV- 4 2), causing the respiratory syndrome known as COVID- 19 . The outbreak has since developed into a 5 global pandemic. As of 3rd August 2020 the number of confirmed COVID-19 cases is approaching 6 18 million, with more than 685,000 deaths occurring worldwide [3] . Faced with these threats, there 7 is a need for robust predictive models that can help policy makers by quantifying the impact of a 8 range of potential responses. However, as is often stated, models are only as good as the data that 9 underpins them; it is therefore important to examine, in some detail, the parameter inference methods 10 and agreement between model predictions and data. 11 In the UK, the first cases of COVID-19 were reported on 31st January 2020 in the city of York. Cases 12 continued to be reported sporadically throughout February and by the end of the month guidance 13 was issued stating that travellers from the high-risk epidemic hotspots of Hubei province in China, 14 Iran and South Korea should self-isolate upon arrival in the UK. By mid-March, as the number of 15 cases began to rise, there was advice against all non-essential travel and, over the coming days, several 16 social-distancing measures were introduced including the closing of schools, non-essential shops, pubs 17 and restaurants. This culminated in the introduction of a UK lockdown, announced on the evening of 18 23rd March, whereby the public were instructed to remain at home with four exceptions: shopping for 19 essentials; any medical emergency; for one form of exercise per day; and to travel to work if absolutely 20 necessary. By mid-April, these stringent mitigation strategies began to have an effect, as the number 21 of confirmed cases and deaths as a result of the disease began to decline. As the number of daily 22 confirmed cases continued to decline during April, May and into June, measures to ease lockdown 23 restrictions began, with the re-opening of some non-essential businesses and allowing small groups of 24 individuals from different households to meet up outdoors, whilst maintaining social distancing. This 25 was followed by gradually re-opening primary schools in England from 1st June and all non-essential 26 retail outlets from 15th June. Predictive models for the UK are therefore faced with a changing set of 27 behaviours against which historic data must be judged, and an uncertain future of potential additional 28 relaxations. 29 Throughout, a significant factor in the decision-making process was the value of the effective reproduc-30 tion number, R of the epidemic; this quantity was estimated by several modelling groups that provided 31 advice through the Scientific Pandemic Influenza Modelling Group (SPI-M) [4] . The Warwick COVID-32 19 model presented here provided one source of R estimates through SPI-M. When R is estimated to 33 be significantly below one, such that the epidemic is exponentially declining, then there is scope for 34 some relaxation of intervention measures. However, as R t approaches one, further relaxation of control 35 may lead to cases starting to rise again. It is therefore crucial that models continue to be fitted to the 36 latest epidemiological data in order for them to provide the most robust information regarding the 37 impact of any relaxation policy and the effect upon the value of R t . It is important to note, however, 38 that there will necessarily be a delay between any change in behaviour, the epidemiological impact 39 and the ability of an statistical method to detect this change.

limitations and the need to assimilate information from multiple sources of data [5] . 48 Throughout this work, the process of model fitting is performed under a Bayesian paradigm, where 49 model parameters are assumed to be random variables and have joint probability distributions [6] . 50 These probability distributions quantify uncertainty in the model parameters, which can be translated 51 into uncertainty in model predictions. We take a likelihood-based approach, in which we define the 52 likelihood (the probability of observing the data given a particular model and parameter set) and 53 use the likelihood to find the probability distribution of our model parameters. In particular, we use 54 Markov Chain Monte Carlo (MCMC) schemes to find the posterior probability distribution of our 55 parameter set given the data and our prior beliefs. MCMC methods construct a Markov chain which 56 converges to the desired posterior parameter distribution at steady state [7] . Simulating this Markov 57 chain thus allows us to draw sets of parameters from the joint posterior distribution. 58 As stated above, the parameter uncertainty may then be propagated if using the model to make projec-59 tions. This affords models with mechanistic aspects, through computational simulation, the capability 60 of providing an estimated range of predicted possibilities given the evidence presently available. Thus, 61 models can demonstrate important principles about outbreaks [8] , with examples during the present 62 pandemic including analyses of the effect of non-pharmaceutical interventions on curbing the outbreak 63 of COVID-19 in the UK [9] . 64 In this paper, we present the inference scheme, and its subsequent refinements, employed for calibrating 65 the Warwick COVID-19 model [10] to the available public health data streams and estimating key 66 epidemiological quantities such as R. 67 We begin by describing our mechanistic transmission model for SARS-CoV-2 in section 2, detailing in 68 section 3 how the effects of social distancing are incorporated within the model framework. In order to 69 fit the model to data streams pertaining to critical care, such as hospital admissions and bed occupancy, 70 section 4 expresses how epidemiological outcomes were mapped onto these quantities. In section 5, we 71 outline how these components are incorporated into the likelihood function and the adopted MCMC 72 scheme. The estimated parameters are then used to measure epidemiological measures of interest, 73 such as the growth rate (r), with the approach detailed in section 6.

The closing sections draw attention to how model frameworks may evolve during the course of a disease 75 outbreak as more data streams become available and we collectively gain a better understanding of the 76 epidemiology (section 7). We explore how key epidemiological quantities, in particular the reproduction 77 number R and the growth rate r, depend on the data sources used to underpin the dynamics. To finish, 78 we outline the latest fits and model generated estimates using data up to mid-June (section 9). 80 We present here the system of equations that account for the transmission dynamics, including symp-81 tomatic and asymptomatic transmission, household saturation of transmission and household quaran-82 tining. The population is stratified into multiple compartments: individuals may be susceptible (S), 83 exposed (E), with detectable infection (symptomatic D), or undetectable infection (asymptomatic, 84 U ). Undetectable infections are assumed to transmit infection at a reduced rate given by τ . We 85 let superscripts denote the first infection in a household (F ), a subsequent infection from a de-86 tectable/symptomatic household member (SD) and a subsequent infection from an asymptomatic 87 household member (SU ). A fraction (H) of the first detected case in a household is quarantined 88 (QF ), as are all their subsequent household infections (QS) -we ignore the impact of household quar-89 antining on the susceptible population as the number in quarantine is assumed small compared with 90 the rest of the population. The recovered class is not explicitly modelled, although it may become 91 important once we have a better understanding of the duration of immunity. Natural demography 92 and disease-induced mortality are ignored in the formulation of the epidemiological dynamics. The full equations are given by

Here we have included M latent classes, giving rise to a Erlang distribution for the latent period, while 96 the infectious period is exponentially distributed. The forces of infection which govern the non-linear 97 transmission of infection obey:

where β H represents household transmission and β N = β S + β W + β O represents all other transmission 99 locations, comprising school-based transmission (β S ), work-place transmission (β W ) and transmission 100 in all other locations (β O ). These matrices are taken from Prem et al [11] , although other sources such 101 as POLYMOD [12] As with any model of this complexity, there are multiple parameters that determine the dynamics. 113 Some of these are global parameters and apply for all geographical regions, with others used to capture 114 the regional dynamics. Some of these parameters are fitted to the early outbreak and other data 115 (table 1) , however the majority are inferred by the MCMC process (table 2) .

Relationship between age-dependent susceptibility and detectability 117 We interlink age-dependent susceptibility, σ a , and detectability, d a , by a quantity Q a . Q a can be 118 viewed as the scaling between force of infection and symptomatic infection. Taking a next-generation 119 approach, the early dynamics would be specified by:

where D a measures those with detectable infections, which mirrors the early recorded age distribution 121 of symptomatic cases. Explicitly, we let d a = 1 κ Q (1−α) a and σ a = 1 k Q α a . As a consequence, Q a = κkd a σ a ; 122 where the parameters κ and k are determined such that the oldest age groups have a 90% probability 123 of being symptomatic (d >90 = 0.90) and such that the basic reproductive ratio from these calculations 124 gives R 0 = 2.7. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 12, 2020. . https://doi.org/10.1101/2020.08.04.20163782 doi: medRxiv preprint Description ε Yes Rate of progression to infectious disease (1/ε is the duration in the exposed class). ε ∼ 0.2 α Yes Scales the degree to which age-structured heterogeneity is due to age-dependent probability of symptoms (α = 0) or age-dependent susceptibility (α = 1) τ Yes Relative level of transmission from asymptomatic compared to symptomatic infection φ R Yes Regional relative strength of the lockdown restrictions; scales the transmission matrices. Can also be varied according to scenario. σ R Yes Regional modifier of susceptibility to account for differences in level of social mixing E R 0 Yes

Initial regional level of infection, rescaled from early age-distribution of cases Start date Yes Regional start date of the epidemic S T No Long term sensitivity of the serological test D R S

Regional scaling for the mortality probability P H→Death a H R S is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 12, 2020. . https://doi.org/10.1101/2020.08.04.20163782 doi: medRxiv preprint

Throughout the current epidemic, there has been noticeable heterogeneity between the different regions 128 of England and between the devolved nations. In particular, London is observed to have a large 129 proportion of early cases and a relatively steeper decline in the subsequent lock-down than the other 130 regions and the devolved nations. In our model this heterogeneity is captured through three regional 131 parameters which act on the heterogeneous population pyramid of each region.

Firstly, the initial level of infection in the region is re-scaled from the early age-distribution of cases, 133 with the regional scaling factor set by the MCMC process. Secondly, we allow the age-dependent 134 susceptibility to be scaled between regions (scaling factor I R ) to account for different levels of social 135 mixing and hence differences in the early R 0 value. Finally, the relative strength of the lockdown 136 (which may be time-varying) is again regional and is determined by the MCMC process. Age-structured contact matrices for the United Kingdom were obtained from Prem et al. [11] and 139 used to provide information on household transmission (β H ab , with the subscript ab corresponding 140 to transmission from age group a against age group b), school-based transmission (β S ab ), work-place 141 transmission (β W ab ) and transmission in all other locations (β O ab ). We assumed that the suite of social-142 distancing and lockdown measures acted in concert to reduce the work, school and other matrices 143 while increasing the strength of household contacts. 144 We capture the impact of social-distancing by defining new transmission matrices (B a,b ) that represent 145 the potential transmission in the presence of extreme lockdown. In particular, we assume that:

while household mixing B H is increased by up to a quarter to account for the greater time spent at 147 home. We take q S = 0.05, q W = 0.2 and q O = 0.05 to approximate the reduction in attendance 148 at school, attendance at workplaces and engagement with shopping and leisure activities during the 149 lock-down, respectively.

For a given compliance level, φ, we generate new transmission matrices as follows:

As such, home and school interactions are scaled between their pre-lockdown values (β) and post-152 lockdown limits (B) by the scaling parameter φ. Work interactions that are not in public-facing 153 'industries' (a proportion 1 -θ) were also assumed to scale in this manner; while those that interact 154 with the general populations (such as shop-workers) were assumed to scale as both a function of their 155 reduction and the reduction of others. We have assumed θ = 0.3 throughout. Similarly, the reduction 156 in transmission in other settings (generally shopping and leisure) has been assumed to scale with the 157 reduction in activity of both members of any interaction, giving rise to a squared term. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 12, 2020. The main model equations focus on the epidemiological dynamics, allowing us to compute the number 160 of symptomatic and asymptomatic infectious individuals over time. However, these quantities are not 161 measured -and even the number of confirmed cases (the closest measure to symptomatic infections) is 162 highly biased by the testing protocols at any given point in time. It is therefore necessary to convert 163 infection estimates into quantities of interest that can be compared to data. We considered six such 164 quantities which we calculated from the number of newly detectable symptomatic infections on a given 165 day nD d . 166 1. Hospital Admissions: We assume that a fraction P D→H a of detectable cases will be admitted 167 into hospital after a delay q from the onset of symptoms. The delay, q, is drawn from a distri-168 bution D D→H q (note that q D D→H q = 1.) Hospital admissions on day d of age a are therefore 169 given by

Similarly, a fraction P D→I a of detectable cases will be admitted into ICU 171 after a delay, drawn from a distribution D D→I q which determines the time between the onset of 172 symptoms and admission to ICU. ICU admissions on day d of age a are therefore given by

3. Hospital Beds Occupied: Individuals admitted to hospital spend a variable number of days in 174 hospital. We therefore define two weightings, which determine if someone admitted to hospital 175 still occupies a hospital bed q days later (T H q ) and if someone admitted to ICU occupies a 176 hospital bed on a normal ward q days later (T I→H q ). Hospital beds occupied on day d of age a 177 are therefore given by

. ICU Beds Occupied: We similarly define T I q as the probability that someone admitted to ICU 179 is still occupying a bed in ICU q days later. ICU beds occupied on day d of age a are therefore 180 given by

. Number of Deaths: The mortality ratio P H→Death a determines the probability that a hospi-182 talised case of a given age, a, dies after a delay, q drawn from a distribution, D H→Death d between 183 hospitalisation and death. The number of deaths on day d of age a are therefore given by

Proportion testing seropositive: Seropositivity is a function of time since the onset of symp-185 toms; we therefore define an increasing sigmoidal function which determines the probability that 186 someone who first displayed symptoms q days ago would generate a positive serology test from 187 a blood sample. The shape of this sigmoidal function is matched to data from PHE, while 188 the asymptote (the long-term sensitivity of the test, S T ) is a free parameter determined by the 189 MCMC. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 12, 2020. .

These nine distributions are all parameterised from individual patient data as recorded by the COVID- 191 19 Hospitalisation in England Surveillance System (CHESS) [13] and the ISARIC WHO Clinical 192 Characterisation Protocol UK (CCP-UK) database sourced from the COVID-19 Clinical Information 193 Network (CO-CIN) [14, 15] . CHESS data is used to define the probabilities of different outcomes 194 (P D→H a , P D→I a , P H→Death a ) due to its greater number of records, while CCP-UK is used to generate 195 the distribution of times (D D→H

) due to its greater detail (Figure 196 S1).

However, these distributions all represent a national average and do not therefore reflect regional 198 differences. We therefore define regional scalings of the three key probabilities (P D→H a , P D→I a and 199 P H→Death a ) and two additional parameters that can stretch (or contract) the distribution of times spent 200 in hospital and ICU. These five regional parameters are necessary to get good agreement between key 201 observations in all regions and may reflect both differences in risk groups (in addition to age) between 202 regions or differences in how the data are recorded between devolved nations. We stress that these 203 parameters do not influence the epidemiological dynamics. This log-likelihood is the key component of the MCMC scheme. In the MCMC process, we apply 210 multiple updates of the parameters using normal or log-normal proposal distributions about the current 211 values. Some parameters (the scaling of age-structure α, the relative transmission rate τ , the latent 212 period 1/ε and the test sensitivity S T ) are global and apply to all regions; new values of these are 213 proposed and the log-likelihood calculated over all 10 regions. Other parameters are regional (such 214 as the relative strength of lockdown restrictions φ R ) and can be updated for each region in turn, the 215 ODEs simulated and stored. Finally another set of regional parameters govern how the ODE output 216 is translated into public health measurable quantities (section 4). These can be rapidly applied to the 217 solution to the ODEs and the likelihood calculated. Given the speed of this last set, multiple proposals 218 are tested for each ODE replicate.

New data are available on a daily time-scale, and therefore inference needs to be repeated on a similar 220 9 . CC-BY 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 12, 2020. . time-scale. We can take advantage of this sequential refitting, by using the posteriors of one inference 221 process as the initial conditions for the next, thus reducing the need for a long burn-in period. The growth rate, r, is defined as the rate of exponential growth (r > 0) or decay (r < 0); and can be 224 visualised as the gradient when plotting observables on a logarithmic scale. Figure 1 shows a simple 225 example, whereby linear trends are fitted to the number of daily hospital admissions (per 100,000 226 people) in London. In this figure, three trend lines are plotted: one before lock-down; one during 227 intense lock-down; and one after partial relaxation on 11th May. This plot clearly highlights the very 228 different speeds between the initial rise and the long-term decline. ; results are plotted on a log scale. Three simple fits to the data are shown for pre-lockdown (red), strictlockdown (blue) and relaxed-lockdown phases (green). Lines are linear fits to the logged data together with 95% confidence intervals, returning average growth rates of 0.21 (doubling every 3.4 days), −0.06 (halving every 11.5 days) and −0.02 (halving every 34 days).

While such statistically simple approaches are intuitively appealing, there are three main drawbacks. 230 Firstly, they are not easily able to cope with the distributed delay between a change in policy (such as 231 the introduction of the lockdown) and the impact of observable quantities (with the delay to deaths 232 being multiple weeks). Secondly, they cannot readily utilise multiple data streams. Finally, they can 233 only be used to extrapolate into the future -extending the period of exponential behaviour -they 234 cannot predict the impact of further changes to policy. Our approach is to instead fit the ODE model 235 to multiple data streams, and then use the daily incidence to calculate the growth rate. Since we use 236 a deterministic set of ODEs, the instantaneous growth rate r can be calculated on a daily basis. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 12, 2020. .

We have two separate methods for calculating R which have been found to be in very close numerical 243 agreement. The first is to calculate R from the next generation matrix β ba /γ using the current 244 distribution of infection across age-classes and states. The second (and numerically simpler method) 245 is to use the relationship between R and r for an SEIR-type model with multiple latent classes, which 246 gives

248 Unsurprisingly, the model framework has evolved during the epidemic as more data streams have 249 become available and as we have gained a better understanding of the epidemiology. Early models 250 were largely based on the data from Wuhan, and made relatively crude assumptions about the times 251 from symptoms to hospitalisation and death. Later models incorporated more regional variation, while 252 the PHE serology data in early May had a profound impact on model parameters. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 12, 2020. . a step-change in the strength of the lockdown restrictions from 13th May (orange) led to substantial 259 over-estimation of future hospital admissions. Across all regions we found some anomalous fits, which 260 are due to changes in the way data were reported (figures S3 and S4). T =t x T ; the prediction error is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 12, 2020. . distributed such that the variance and mean are equal. The other two graphs show how the error in 270 the prediction has dropped over time from very high values for simulations in early April (when the 271 impact of the lockdown was uncertain) to values in late May and June that are comparable with the 272 error from the moving average. The likelihood expression given above is an idealised measure, and depends on all the observed data 275 streams being available and unbiased. Unfortunately, ICU admission data have not been available to 276 date, and there are subtle differences in data streams between the devolved nations. An important 277 question is therefore how key epidemiological quantities (and in particular the reproduction number 278 R and the growth rate r) depend on the data sources used to underpin the dynamics. 279 Fig. 4 : Impact of a change in underlying restrictions on the growth rate of modelled data streams. A change in the underlying restrictions occurs at time zero, taking the asymptotic growth rate r from ≈ −0.026 to ≈ +0.01. This change is reflected in an increase in growth rate of five key epidemiological quantities, which reach the true theoretical growth rate at different times.

In a high dimensional systems with different temporal lags (see Figure S1 ), there are inevitably different 280 time-scales from when a change in policy or adherence occurs and when its impact is observed in key 281 quantities. We briefly assess this problem in Figure 4 , by introducing a change in the strength of 282 lock-down restrictions (φ) and recording the subsequent rates of change of five key model parameters 283 (infections, symptomatic cases, hospitalisations, admission to ICU and Deaths). Unsurprisingly, the 284 impact of this change in restrictions takes the longest time to resolve in the mortality, taking around 285 seven weeks to realise the true growth rate. Even measures which should be more immediate, such 286 as the growth of symptomatic cases, take some time to settle to the theoretical growth rate given the 287 high dimensionality of the age-structured model. This all strongly suggests that at best our estimates 288 of r and hence R will not be able to rapidly detect changes to the underlying behaviour. figure S5 ). Five different choices are shown: matching to recorded deaths only (using the 291 date of death); matching to hospital admissions (both in-patients testing positive and admissions of 292 individuals who have already tested positive); matching to bed occupancy, both hospital wards and 293 ICU; matching to a combination of deaths and admissions; and finally matching to all data. In general 294 we find that just using reported deaths produces the greatest spread of growth rates (r), presumably 295 because deaths represent a small fraction of the total outbreak, and therefore naturally introduce 296 13 . CC-BY 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 12, 2020. . https://doi.org/10.1101/2020.08.04.20163782 doi: medRxiv preprint more uncertainty. Using hospital admissions (with or without deaths) generates similar predictions 297 and similar levels of uncertainty in predictions. 298 Fig. 5 : Impact of data streams and model structure on estimated growth rate. Here the growth rates are estimated using the predicted rate of change of new cases for London on 10th June 2020, with parameters inferred using data until 9th June. (a) The impact of restricting the inference to different data streams (deaths only, hospital admissions, hospital bed occupancy, deaths and admissions or all data); serology data was included in all inference. (b) The impact of having different numbers of lockdown phases (while using all the data); the default is 3 (as in Figure 1 ).

As mentioned in section 7, the number of phases used to describe the reduction in transmission due to 299 lockdown has changed as the situation, model and data evolved. The model began with just two phases; 300 before and after lockdown. However, in late May, following the policy changes on 13th May, we explored 301 having three phases. Having three phases is equivalent to assuming the same level of adherence to 302 the lockdown and social-distancing measures throughout the epidemic, with changes in transmission 303 occurring only due to the changing policy on 23rd March and 13th May. However, different number 304 of phases can be explored (figure 5, right panel). Moving to four phases (with two equally spaced 305 within the more relaxed lockdown) increases the variation, but does not have a substantial impact on 306 the mean. Allowing eight phases (spaced every two weeks throughout lockdown) dramatically changes 307 our estimation of the growth rate as the parameter inference responds more quickly to minor changes 308 in observable quantities.

Lastly, it has been recently noted that one of the quantities used throughout the outbreak (number of 310 daily hospital admissions) could be biasing the model fitting. Hospital admissions for COVID-19 are 311 comprised of two measures: 312 (i) In-patients that test positive; this includes both individuals entering hospital with COVID-19 313 symptoms who subsequently test positive, and hospital acquired infections. Given that both of 314 these elements feature in the hospital death data, it is difficult to separate them.

(ii) Patients arriving at hospital who have previously tested positive. In the early days of the 316 outbreak, these were individuals who had been swabbed just prior to admission; however in the 317 latter stages there are many patients being admitted for non-COVID related problems that have 318 previously tested positive.

It seems prudent to remove this second element from our fitting procedure, although we note that 320 for the devolved nations this separation into in-patients and new admissions is less clear. Removing 321 this component of admissions also means that we cannot use the number of occupied beds as part 322 of the likelihood, as these cannot be separated by the nature of admission. In figure 6 we therefore 323 14 . CC-BY 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 12, 2020. . compare the default fitting (used throughout this paper) with an updated method that uses in-patient 324 admissions (together with deaths, ICU occupancy and serology when available). We observe that 325 restricting the definition of hospital admission leads to a slight reduction in the growth rate r but a 326 more pronounced reduction in the incidence. 327 328 Fig. 6 : Impact of including different types of hospital admission in parameter inference. Growth rates and total incidence (asymptomatic and symptomatic) estimated from the ODE model for June 10th 2020 in London. In each panel, blue dots (on the left-hand side) give estimates when using all hospital admissions in the parameter inference (together with deaths, ICU occupancy and serology when available); red dots (on the right-hand side) represent estimates obtained using an alternative inference method that restricted to fitting to in-patient hospital admission data (together with deaths, ICU occupancy and serology when available). Parameters were inferred using data until 9th June, while the r value comes from the predicted rate of change of new cases.

Using the most recent fit to the data (as of the time of writing), which was performed on 14th 330 June using in-patient data, ICU occupancy, date of death records and serological results, we analysed 331 growth rate predictions and how growth rate predictions inferred at earlier times compare to current 332 estimates. We focus on London and the North East and Yorkshire region, with other regions given in 333 the Supplementary Material.

The time profile of predicted growth rate illustrates how the imposition of lockdown measures on 335 23rd March led to r decreasing below 0. The predicted growth rate is not a step function as changes 336 to policy precipitate changes to the age-distribution of cases which has second-order effects on r. 337 The second change in φ (the relative strength of lockdown restrictions) on 13th May, leads to an 338 increase in r in all regions, although London shows one of the more pronounced increases. Despite 339 this most recent increase, models estimates suggest r remained below 0 across all regions as of 14th 340 June (figure 7).

Early changes in advice prior to the introduction of lockdown measures were also included in the model, 342 such as social distancing, encouragement to work from home (from 16th March) and the closure of 343 all restaurants, pubs, cafes and schools on 20th March. For all regions, we observe minor declines in 344 the estimated growth rate following introduction of these measures, though the estimated growth rate 345 remained above 0 (figure 7). As the model has evolved and the data streams become more complete, 346 we have generally converged on the estimated growth rates from current inference. It is clear that it 347 15 . CC-BY 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 12, 2020. . . These predictions are from the date the MCMC inference is performed. The solid blue line (together with 50% and 95% credible intervals) shows our estimate of r through time using the most recent fit to the data (performed on 14th June restricting hospital data to in-patient data only). Vertical dashed lines show the two dates of main changes in policy, reflected in different regional φ values. Early changes in advice, such as social distancing, self isolation and working from home were also included in the model and their impact can be seen in minor declines in the estimated growth rate. takes around 20 days from the time changes are enacted for them to be robustly incorporated into 348 model parameters (see dots and 95% credible intervals in figure 7) . 349 Using parameters drawn from the posterior distributions, the model produces predictive posterior 350 distributions for multiple health outcome quantities that have a strong quantitative correspondence 351 to the regional observations (figure 8). We recognise there was a looser resemblance to data on 352 seropositivity, though salient features of the temporal profile are captured. In addition, short-term 353 forecasts for each measure of interest have been made by continuing the simulation beyond the date 354 of the final available data point, assuming that behaviour remains as of the final period (starting 13th 355 May).

In this study, we have provided an overview of the evolving MCMC inference scheme employed for 358 calibrating the Warwick COVID-19 model [10] to the available health care, mortality and serological 359 data streams. A comparison of model short-term predictions and data over time (i.e. as the outbreak 360 has progressed) demonstrated an observable decline in the error -suggesting that our model and 361 inference methods have improved. We have considered in some detail the choice of data sets used to 362 infer model parameters and the impact of this choice on the key emergent properties of the growth 363 rate r and the reproductive number R. We highlight that many of the decisions about which data 364 sets to utilise are value judgements based on an epidemiological understanding of the relationships 365 between disease dynamics and observed outcomes. None of the data sets available to epidemiological 366 modellers are perfect, all have biases and delays; here we believe that by using multiple data sources in 367 a Bayesian framework we arrive at a model that achieves a natural compromise. In particular, we have 368 highlighted how single measures such as the number of daily deaths generate considerable uncertainty 369 in the predicted growth rate ( Figure 5 ) and may be slower to identify changes in behaviour (Figure 4) . is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 12, 2020. . is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 12, 2020. . https://doi.org/10.1101/2020.08.04.20163782 doi: medRxiv preprint a COVID hospitalisation ( Figure 6 ) is shown to cause a slight difference in the estimated growth rate 372 r but a more marked discrepancy in incidence. 373 It is important that uncertainty in the parameters governing the transmission dynamics, and its 374 influence on predicted outcomes, be robustly conveyed. Without it, decision makers will be missing 375 meaningful information and may assume a false sense of precision. MCMC methodologies were a 376 suitable choice for inferring parameters in our model framework, since we were able to evaluate the 377 likelihood function quickly enough to make the approach feasible. Nevertheless, for some model 378 formulations and data, it may not be possible to write down or evaluate the likelihood function. In 379 these circumstances, an alternative approach to parameter inference is via simulation-based, likelihood-380 free methods, such as Approximate Bayesian Computation [16] [17] [18] .

As we gain collective understanding of the SARS-CoV-2 virus and the COVID-19 disease it causes, 382 the structure of infectious disease transmission models, the inference procedure and the use of data 383 streams to underpin these models must continuously evolve. The evolution of the model to date is 384 documented here (Figures 2 and 7) , we feel it is important to show this evolving process rather than 385 simply present the final finished product. A vast body of work exists describing mathematical models 386 for different infectious outbreaks and the associated parameter inference from epidemiological data. 387 In most cases, however, these models are fitted retrospectively, using the entire data that have been 388 collected during an outbreak. Fitting models with such hindsight is often far more accurate than 389 predictions made in real-time. In the case when models are deployed during active epidemics, there 390 are also additional challenges associated with the rapid flow of detailed and accurate data. Even if 391 robust models and methods were available from the start of an outbreak, there are still significant 392 delays in obtaining, processing and inferring parameters from new information [5] . This is particularly 393 crucial as new interventions are introduced or significant policy changes occur, such as the relaxation 394 of multiple non-pharmaceutical interventions during May, June and July of 2020 or the introduction of 395 the nationwide "test and trace" protocol [19] . Predicting the impact of such changes will inevitability 396 be delayed by the lag between deployment and the effects on observable quantities (Figure 4 ) as well 397 as the potential need to reformulate model structure or incorporate new data streams.

Multiple refinements to the model structure are still possible, and may yield a better understanding 399 of the epidemic to date. Recent immunological assessments find evidence of some infected individ-400 uals becoming seronegative within eight weeks of hospital discharge [20] , this waning seropositivity 401 mechanism could warrant inclusion in the model, which may also strengthen correspondence to later 402 serology data where a potential decline may already be observed. (It is worth stressing that we a 403 describing a waning of the ability to detect that someone has been infected, rather than a direct 404 waning of the immune respond and therefore reversion to susceptibility.) The knowledge that infec-405 tion may be partially driven by nosocomial transmission [21, 22] , while significant mortality is due to 406 infection in care homes [23, 24] , suggests that additional compartments capturing these components 407 could greatly improve model realism if the necessary data were available throughout the course of 408 the epidemic. Additionally, as we approach much lower levels of infection in the community, it may 409 be prudent to adopt a stochastic model formulation at a finer spatial resolution to capture localised 410 outbreak clusters. Finally, more consideration could be given to detecting changes in the strength of 411 lockdown restrictions (φ). In this model φ was inferred in two main phases the main lockdown (from 412 23rd March to 13th May) and the more relaxed restrictions (from 13th May); in practice there will be 413 continuous changes to this quantity as the population's behaviour varies, assessing the correct scale 414 for capturing this variation is a key challenge for this approach.

In summary, if epidemiological models are to be used as part of the scientific discussion of controlling 416 a disease outbreak it is vital that these models capture current biological understanding and are 417 continually matched to all available data in real time. Our work on COVID-19 presented here highlights 418 18 . CC-BY 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 12, 2020. . some of the challenges with predicting a novel outbreak in a rapidly changing environment. Probably 419 the greatest weakness is the time that it inevitably takes to respond -both in terms of developing 420 the appropriate model and inference structure, and the mechanisms to process any data sources, but 421 also in terms of delay between real-world changes and their detection within any inference scheme. 422 Both of these can be shortened by well-informed preparations: having the necessary suite of models 423 supported by the latest most efficient inference techniques could be hugely beneficial when rapid and 424 robust predictive results are required. 425 

. CC-BY 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 12, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 12, 2020. . Data from the CHESS database were supplied after anonymisation under strict data protection pro-460 tocols agreed between the University of Warwick and Public Health England. The ethics of the use of 461 these data for these purposes was agreed by Public Health England with the Government's SPI-M(O) 462 / SAGE committees.

Data availability 464 This work uses data provided by patients and collected by the NHS as part of their care and sup-465 port #DataSavesLives. We are extremely grateful to the 2,648 frontline NHS clinical and research 466 staff and volunteer medical students, who collected this data in challenging circumstances; and the 467 generosity of the participants and their families for their individual contributions in these difficult 468 times. The CO-CIN data was collated by ISARIC4C Investigators. ISARIC4C welcomes applica-469 tions for data and material access through our Independent Data and Material Access Committee 470 (https://isaric4c.net).

Data on cases were obtained from the COVID-19 Hospitalisation in England Surveillance System 472 (CHESS) data set that collects detailed data on patients infected with COVID-19. Data on COVID-473 19 deaths were obtained from Public Health England. These data contain confidential information, 474 with public data deposition non-permissible for socioeconomic reasons. The CHESS data resides with 475 the National Health Service (www.nhs.gov.uk) whilst the death data are available from Public Health 476 England (www.phe.gov.uk).

. CC-BY 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 12, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 12, 2020. . https://doi.org/10.1101/2020.08.04.20163782 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 12, 2020. . https://doi.org/10.1101/2020.08.04.20163782 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 12, 2020. . https://doi.org/10.1101/2020.08.04.20163782 doi: medRxiv preprint For all daily hospital deaths with COVID-19 in each region, we show the raw data (block dots) and a set of short-term predictions generated at different points during the outbreak. Changes to model fit reflect both improvements in model structure as well as increased amounts of data.

. CC-BY 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 12, 2020. . https://doi.org/10.1101/2020.08.04.20163782 doi: medRxiv preprint Fig. S5 : Impact of data streams on estimated growth rates, by region. The impact on the regional growth rate (estimated from the ODE epidemic on 10th June 2020) of restricting the inference to different data streams (deaths only, hospital admissions, hospital bed occupancy, deaths and admissions or all data); the serology data was included in all inference. Parameters were inferred using data until 9th June, while the r value comes from the change in predicted rate of change of new cases.

. CC-BY 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 12, 2020. . https://doi.org/10.1101/2020.08.04.20163782 doi: medRxiv preprint Fig. S6 : Impact of model structure on estimated growth rates, by region. Analysis of having different numbers of lockdown phases on the estimated regional growth rate on 10th June 2020, while using all the data.

The number of lockdown phases tested were there (blue dots), four (green dots) and eight (red dots). Parameters were inferred using data until 9th June, while the r value comes from the change in predicted rate of change of new cases.

. CC-BY 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 12, 2020. . https://doi.org/10.1101/2020.08.04.20163782 doi: medRxiv preprint Fig. S7 : Impact of including different types of hospital admission in parameter inference on the estimated regional growth rates (on 10th June 2020). For each region, growth rates were estimated from the ODE epidemic for 10th June 2020. In each panel, blue dots (on the left-hand side) give r estimates when using all hospital admissions in the parameter inference (together with deaths, ICU occupancy and serology when available); red dots (on the right-hand side) represent r estimates using an alternative inference method that restricted to fitting to in-patient hospital admission data (together with deaths, ICU occupancy and serology when available). Parameters were inferred using data until 9th June, while the r value comes from the change in predicted rate of change of new cases. We observe that restricting the definition of hospital admission leads to a slight reduction in the growth rate r but a more pronounced reduction in the incidence. (This separation is not possible for the devolved nations, but the associated distributions are shown for completeness.)

. CC-BY 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 12, 2020. . https://doi.org/10.1101/2020.08.04.20163782 doi: medRxiv preprint Fig. S8 : Impact of including different types of hospital admission in parameter inference on the daily incidence (on 10th June 2020). For each region, daily incidences were estimated from the ODE epidemic for 10th June 2020. In each panel, blue dots (on the left-hand side) give incidence estimates when using all hospital admissions in the parameter inference (together with deaths, ICU occupancy and serology when available); red dots (on the right-hand side) represent incidence estimates using an alternative inference method that restricted to fitting to in-patient hospital admission data (together with deaths, ICU occupancy and serology when available). Parameters were inferred using data until 9th June. We observe that restricting the definition of hospital admission leads to a pronounced reduction in the incidence. (This separation is not possible for the devolved nations, but the associated distributions are shown for completeness.)

. CC-BY 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 12, 2020. . Fig. S9 : Evolution of growth rate predictions and most recent model estimates in each of the ten regions. For each region, we show how predictions of r have evolved over time (dots and 95% credible intervals). These predictions are from the date the MCMC inference is performed. The solid blue line (together with 50% and 95% credible intervals) shows our estimate of r through time using the most recent fit to the data (performed on 14th June using in-patient data only). Vertical dashed lines show the two dates of main changes in policy, reflected in different regional φ values.

. CC-BY 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 12, 2020. . https://doi.org/10.1101/2020.08.04.20163782 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 12, 2020. . https://doi.org/10.1101/2020.08.04.20163782 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 12, 2020. . https://doi.org/10.1101/2020.08.04.20163782 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 12, 2020. . https://doi.org/10.1101/2020.08.04.20163782 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 12, 2020. . https://doi.org/10.1101/2020.08.04.20163782 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 12, 2020. . https://doi.org/10.1101/2020.08.04.20163782 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 12, 2020. . https://doi.org/10.1101/2020.08.04.20163782 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 12, 2020. . https://doi.org/10.1101/2020.08.04.20163782 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 12, 2020. . https://doi.org/10.1101/2020.08.04.20163782 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted August 12, 2020. . https://doi.org/10.1101/2020.08.04.20163782 doi: medRxiv preprint

Rachel Prout, Nikolas Rae, Henrik Reschre-550 iter

A Novel Coronavirus from Patients with Pneumonia in China

World Health Organization. Novel Coronavirus (2019-nCoV) Situation Report -1

World Health Organization. Coronavirus diseases (COVID-19) Situation Report -196

Scientific Pandemic Influenza Group on Modelling (SPI-M

Four key challenges in infectious disease modelling using data from multiple sources

Bayesian Data Analysis

Handbook of Markov Chain Monte Carlo

Epidemiological models are important tools for guiding COVID-19 interventions

Effects of nonpharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study

Predictions of COVID-19 dynamics in the UK: short-term forecasting and analysis of potential exit strategies

Projecting social contact matrices in 152 countries using contact surveys and demographic data

Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases

COVID-19 Hospitalisation in England Surveillance System (CHESS) -daily reporting

Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study

Coronavirus Clinical Characterisation Consortium

Adaptive approximate Bayesian computation

Approximate Bayesian computation scheme for parameter inference and model selection in dynamical systems

Inference in Epidemic Models without Likelihoods

Department of Health and Social Care

Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections

Nosocomial infections among patients with COVID-19, SARS and MERS: a rapid review and meta-analysis

The impact of testing and infection prevention and control strategies on within-hospital transmission dynamics of COVID-19 in English hospitals

Covid-19: Care home deaths in England and Wales rise sharply

Sars-cov-2 infection, clinical features and outcome of covid-19 in united kingdom nursing homes